secwatch.observer — SEC 8-K summary
======================================

Issuer:     Esperion Therapeutics, Inc. (ESPR)
CIK:        0001434868
Form:       8-K
Filed at:   2026-07-08T12:32:50+00:00
Accession:  0001104659-26-081588
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Esperion shareholders approve merger with Essence Parent Inc.
-------------------------------------------------------------

- Merger Agreement approved with 135,326,793 votes for, 22,750,628 against, 496,194 abstentions.
- Advisory compensation proposal approved with 129,937,383 votes for, 22,283,787 against, 6,352,445 abstentions.
- Quorum of 61.53% of outstanding shares represented at July 8, 2026 special meeting.
- MergerCo will merge into Esperion, which will survive as wholly owned subsidiary of Parent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434868/000110465926081588/0001104659-26-081588-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434868/000110465926081588/tm2620034d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-081588

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer